Notice of Intent to Sole Source – SynapseVNA
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The National Institutes of Health (NIH), specifically the Clinical Center, has issued a Notice of Intent to Sole Source for a one-year contract to Fuji Medical (formerly TeraMedica). This procurement is for the maintenance and technical support of the SynapseVNA product, which is critical for the ResearchPACS system maintained by RADIS/CC. This is not a request for quotation, and a solicitation will not be issued.
Scope of Work
- Maintain the current Fuji Medical SynapseVNA product at the latest revision level.
- Provide necessary technical support for the SynapseVNA product.
Contract & Timeline
- Type: Notice of Intent (Sole Source)
- Duration: One-year contract, from September 4, 2026, to September 3, 2027.
- Set-Aside: Not Applicable (Sole Source)
- Comments Due: May 14, 2026, 12pm EST
- Published: May 7, 2026
Justification
Fuji Medical is identified as the developer, sole licensor, and sole provider of technical support for the Synapse family of products. Therefore, they are the only entity capable of providing the required technical updates and support services. This acquisition is being conducted under FAR Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), which allows for soliciting from a single source when circumstances deem only one source reasonably available.
Additional Notes
Comments referencing this posting number should be submitted to Ryssa Nix, Contract Specialist, via email at Ryssa.nix@nih.gov prior to the closing date.